EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MF1, a novel robustic acid derivative, exerts antitumor effects in hepatocellular carcinoma

Juanjuan Huang, Lijuan Teng, Tianxiu Meng, Yuqiong Liang, Yaoqi Li, Jinyan Lv

Translational Oncology · 2026-12 · 74 · 103086

DOI: 10.1016/j.tranon.2026.103086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2026-12. Verfasst von Juanjuan Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chinese Medicine Science, Guangxi University of Chinese Medicine, Nanning, Guangxi Zhuang Autonomous Region, 530004, China; Krirk Universi…. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Middle-aged and Young Teachers' Basic Ability Promotion Project of Guangxi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) extensive genomic heterogeneity and immunosuppressive tumor immune microenvironment (TIME) are major factors contributing to treatment resistance. This study aims to elucidate the molecular mechanisms by which Robustic Acid 4-O-amino substituted synthetic derivatives (MF1), a novel robustic acid derivative, derived from structural modifications of natural products from Dalbergia benthamii Prain, targets carcinogenic signaling and synergistically regulates the crosstalk between autophagy and ferroptosis to induce programmed cell death in HCC. In vitro functional assays confirmed that MF1 exhibits significant antitumor activity. Mechanistically, MF1 significantly upregulates cellular oxidative stress levels, inducing characteristic changes in mitochondrial ultrastructure and apoptosis; simultaneously, by promoting intracellular Fe²⁺ accumulation and downregulating the expression of key ferroptosis regulators GPX4 and SLC7A11, it potently activates the ferroptosis process. Concurrently, MF1 continuously activates the cytotoxic autophagy pathway by regulating the LC3 I/II conversion ratio and upregulating the expression of core autophagy proteins ATG5 and Beclin-1. Network pharmacology identified 7 core targets of MF1 that are common to both ferroptosis and autophagy regulation. qPCR validation showed that MF1 significantly downregulated the mRNA expression of these 7 core oncogenes in HepG2 cells. Molecular docking confirmed strong binding affinities between MF1 and five core targets, 100 ns all-atom molecular dynamics simulations further validated the conformational stability of all five top-ranked MF1-protein complexes, with the higher binding stability for AKT1, SRC and MTOR. In summary, this study clarifies MF1 induces apoptosis and ferroptosis in HepG2 cells, suggesting its potential as a new therapeutic option for HCC.

Schlagwörter

Stichwörter der Autor:innen

AntitumorAutophagyFerroptosisHepatocellular carcinomaMF1

Autor:innen und Institutionen

  • Faculty of Chinese Medicine Science, Guangxi University of Chinese Medicine, Nanning, Guangxi Zhuang Autonomous Region, 530004, China; Krirk University, Bangkhen, Bangkok, 10220, Thailand. Electronic address: hjjcbw@163…
  • Faculty of Chinese Medicine Science, Guangxi University of Chinese Medicine, Nanning, Guangxi Zhuang Autonomous Region, 530004, China. Electronic address: tlj3930873@163.com.
  • Faculty of Chinese Medicine Science, Guangxi University of Chinese Medicine, Nanning, Guangxi Zhuang Autonomous Region, 530004, China. Electronic address: mtx569267@163.com.
  • Faculty of Chinese Medicine Science, Guangxi University of Chinese Medicine, Nanning, Guangxi Zhuang Autonomous Region, 530004, China. Electronic address: liangyuqiongyl@126.com.
  • School of Public Health, Yale University, New Haven, CT, 06510, USA. Electronic address: deniselll877@gmail.com.
  • Faculty of Chinese Medicine Science, Guangxi University of Chinese Medicine, Nanning, Guangxi Zhuang Autonomous Region, 530004, China. Electronic address: m13737089920@163.com.

Förderung

  • Middle-aged and Young Teachers' Basic Ability Promotion Project of Guangxi

Zitieren

APA

Huang, J., Teng, L., Meng, T., Liang, Y., Li, Y., & Lv, J. (2026). MF1, a novel robustic acid derivative, exerts antitumor effects in hepatocellular carcinoma. Translational Oncology, 74, 103086. https://doi.org/10.1016/j.tranon.2026.103086

Vancouver

Huang J, Teng L, Meng T, Liang Y, Li Y, Lv J. MF1, a novel robustic acid derivative, exerts antitumor effects in hepatocellular carcinoma. Translational Oncology. 2026;74:103086. doi:10.1016/j.tranon.2026.103086

BibTeX
@article{Huang2026,
  author = {Huang, Juanjuan and Teng, Lijuan and Meng, Tianxiu and Liang, Yuqiong and Li, Yaoqi and Lv, Jinyan},
  title = {MF1, a novel robustic acid derivative, exerts antitumor effects in hepatocellular carcinoma},
  journal = {Translational Oncology},
  year = {2026},
  volume = {74},
  pages = {103086},
  doi = {10.1016/j.tranon.2026.103086}
}
Kostenlos starten →